PROTEOMONITOR SUBSCRIBERS: MDS and Cellzome Interaction Data Don t Match: Are Standards a Solution?

Feb 04, 2002

This story is available to ProteoMonitor subscribers.

Breaking News

Bio-Rad Laboratories Q2 Revenues Climb 33 Percent, Beat Estimates
Veracyte Q2 Revenues More Than Double on Test Volume Spike
Increased Testing Revenues Boost Opko Health Q2 Revenues 47 Percent
Qiagen Q2 Revenues Grow 28 Percent
CareDx Q2 Revenues Up 77 Percent
Secondary Genetic Findings Often Requested if Given Second Chance, Study Finds

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.

PROTEOMONITOR SUBSCRIBERS: MDS and Cellzome Interaction Data Don t Match: Are Standards a Solution?

Bio-Rad Laboratories Q2 Revenues Climb 33 Percent, Beat Estimates

Veracyte Q2 Revenues More Than Double on Test Volume Spike

Increased Testing Revenues Boost Opko Health Q2 Revenues 47 Percent

Qiagen Q2 Revenues Grow 28 Percent

CareDx Q2 Revenues Up 77 Percent

Secondary Genetic Findings Often Requested if Given Second Chance, Study Finds

Booster Push

With Help from Mr. Fluffington, PurrhD

Man Charged With Threatening to Harm Fauci, Collins

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

CDC to Withdraw EUA for COVID-19 Test; FDA Revokes Three Other EUAs for Non-Use, Agency Clearance

FDA Clears Promega Microsatellite Instability Test System

Strata Oncology Raises $90M in Series C Financing

Thermo Fisher Scientific Q2 Revenues up 34 Percent

Polygenic Cancer Risk Score Mitigated by Healthy Lifestyle, Study Suggests